BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33448128)

  • 21. Jaffe-Campanacci syndrome or neurofibromatosis type 1: a case report of phenotypic overlap with detection of NF1 gene mutation in non-ossifying fibroma.
    Vannelli S; Buganza R; Runfola F; Mussinatto I; Andreacchio A; de Sanctis L
    Ital J Pediatr; 2020 May; 46(1):58. PubMed ID: 32393377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Segmental neurofibromatosis in children. Presentation of 43 patients].
    Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; López-Gutiérrez JC
    Rev Neurol; 2008 Oct 16-31; 47(8):399-403. PubMed ID: 18937200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial unilateral lentiginosis is mosaic neurofibromatosis type 1 or not?
    Yaşar Ş; Ersanli A; Göktay F; Aytekin S; Cebeci D; Güneş P
    J Dermatol; 2017 Jan; 44(1):29-35. PubMed ID: 27439996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Imaging features of neurofibromatosis type 1].
    Jacques C; Dietemann JL
    J Neuroradiol; 2005 Jun; 32(3):180-97. PubMed ID: 16134300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mosaic Neurofibromatosis Type 1 With Multiple Cutaneous Diffuse and Plexiform Neurofibromas of the Lower Leg.
    Friedrich RE; Hagel C; Kohlrusch FK; Schanze I; Wieland I; Zenker M
    Anticancer Res; 2020 Jun; 40(6):3423-3427. PubMed ID: 32487640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ectropion Uveae in neurofibromatosis type 1: a new manifestation.
    Iacovino C; Miraglia E; Moramarco A; Corbo G; Lambiase A; Giustini S
    Clin Ter; 2021 May; 172(3):206-208. PubMed ID: 33956037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Sonographic Classification of Neurofibromas in Children with Neurofibromatosis Type 1 - A Cluster Analysis.
    García-Martínez FJ; Alfageme F; Duat-Rodríguez A; Andrés Esteban EM; Hernández-Martín A
    Ultraschall Med; 2023 Apr; 44(2):e118-e125. PubMed ID: 34820795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait macules.
    Ben-Shachar S; Dubov T; Toledano-Alhadef H; Mashiah J; Sprecher E; Constantini S; Leshno M; Messiaen LM
    J Am Acad Dermatol; 2017 Jun; 76(6):1077-1083.e3. PubMed ID: 28318682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exuberant manifestation of neurofibromatosis type 1 affecting 3 generations: delayed diagnosis and the importance of the multidisciplinary approach.
    Tolentino ES; Souza Pinto GN; Maciel L; Soares CT; Lara VS; Moreschi ARC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Sep; 128(3):e108-e112. PubMed ID: 31101459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary spinal neurofibromatosis: a rare form of NF1?
    Poyhonen M; Leisti EL; Kytölä S; Leisti J
    J Med Genet; 1997 Mar; 34(3):184-7. PubMed ID: 9132486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.
    Legius E; Brems H
    Childs Nerv Syst; 2020 Oct; 36(10):2285-2295. PubMed ID: 32601904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnostic and clinical significance of café-au-lait macules.
    Shah KN
    Pediatr Clin North Am; 2010 Oct; 57(5):1131-53. PubMed ID: 20888463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occult neurofibroma and increased S100 protein in the skin of patients with neurofibromatosis type 1: new insight to the etiopathomechanism of neurofibromas.
    Karvonen SL; Kallioinen M; Ylä-Outinen H; Pöyhönen M; Oikarinen A; Peltonen J
    Arch Dermatol; 2000 Oct; 136(10):1207-9. PubMed ID: 11030766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
    Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
    Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pigmented plexiform neurofibroma: Distinction from a large congenital melanocytic nevus.
    Schaffer JV; Chang MW; Kovich OI; Kamino H; Orlow SJ
    J Am Acad Dermatol; 2007 May; 56(5):862-8. PubMed ID: 17280739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas.
    Overdiek A; Feifel H; Schaper J; Mayatepek E; Rosenbaum T
    Brain Dev; 2006 Jun; 28(5):275-80. PubMed ID: 16481142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Segmental neurofibromatosis in childhood.
    Listernick R; Mancini AJ; Charrow J
    Am J Med Genet A; 2003 Aug; 121A(2):132-5. PubMed ID: 12910491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facial plexiform neurofibroma in a child with neurofibromatosis type I: a case report.
    Patil K; Mahima VG; Shetty SK; Lahari K
    J Indian Soc Pedod Prev Dent; 2007 Mar; 25(1):30-5. PubMed ID: 17456965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of growth hormone deficiency combined with neurofibromatosis Type 1 and its gene analysis].
    Long X; Xiong J; Mo Z; Zhang Q; Jin P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):811-815. PubMed ID: 30124220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.